- 優先名称
- Chlorophenylalanyl-cyclo(cysteinyl-1-oxohexadecyl-tryptophyl-lysyl-valyl-cysteinyl)-chlorophenylalanylamide
- IUPAC
- (4R,7S,10S,13R,16S,19S)-10-(4-aminobutyl)-N-[(2S)-1-amino-3-(4-chlorophenyl)-1-oxopropan-2-yl]-19-[[(2S)-2-amino-3-(4-chlorophenyl)propanoyl]amino]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-16-(pyridin-3-ylmethyl)-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
- 現地名
- 4-クロロ-L-Phe-D-Cys(1)-3-(3-ピリジル)-L-Ala-D-Trp-L-Lys-L-Val-L-Cys(1)-4-クロロ-L-Phe-NH2
- 英語名
- SB-710411
- 分子式
- C54H66Cl2N12O8S2
- 分子量
- 1146.21
名称と別名
209006-05-3SB 710411Cpa-c(D-Cys-Pal-D-Trp-Lys-Val-Cys)-Cpa-amideChlorophenylalanyl-cyclo(cysteinyl-1-oxohexadecyl-tryptophyl-lysyl-valyl-cysteinyl)-chlorophenylalanylamideSB-710411(4R,7S,10S,13R,16S,19S)-10-(4-Aminobutyl)-N-[(2S)-1-amino-3-(4-chlorophenyl)-1-oxopropan-2-yl]-19-[[(2S)-2-amino-3-(4-chlorophenyl)propanoyl]amino]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-16-(pyridin-3-ylmethyl)-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamideL-Phenylalaninamide, 4-chloro-L-phenylalanyl-D-cysteinyl-3-(3-pyridinyl)-L-alanyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-4-chloro-, cyclic (2-7)-disulfide4-クロロ-L-Phe-D-Cys(1)-3-(3-ピリジル)-L-Ala-D-Trp-L-Lys-L-Val-L-Cys(1)-4-クロロ-L-Phe-NH2(2S)-2-アミノ-N-[(4R,7S,10S,13R,16S,19S)-10-(4-アミノブチル)-4-{[(1S)-1-カルバモイル-2-(4-クロロフェニル)エチル]カルバモイル}-13-[(1H-インドール-3-イル)メチル]-6,9,12,15,18-ペンタオキソ-7-(プロパン-2-イル)-16-[(ピリジン-3-イル)メチル]-1,2-ジチア-5,8,11,14,17-ペンタアザシクロイコサン-19-イル]-3-(4-クロロフェニル)プロパンアミドUROTENSIN II RECEPTOR ANTAGONIST